These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15578955)

  • 21. (68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives.
    Breeman WA; de Blois E; Sze Chan H; Konijnenberg M; Kwekkeboom DJ; Krenning EP
    Semin Nucl Med; 2011 Jul; 41(4):314-21. PubMed ID: 21624565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radionuclides and radiopharmaceuticals for single-photon emission tomography, positron emission tomography and radiotherapy in Russia.
    Krasikova RN; Kodina GE
    Eur J Nucl Med; 1999 Jul; 26(7):774-88. PubMed ID: 10398826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PET & SPECT instrumentation.
    Spanoudaki VC; Ziegler SI
    Handb Exp Pharmacol; 2008; (185 Pt 1):53-74. PubMed ID: 18626798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Instrumentation for molecular imaging in preclinical research: Micro-PET and Micro-SPECT.
    Chatziioannou AF
    Proc Am Thorac Soc; 2005; 2(6):533-6, 510-11. PubMed ID: 16352760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of imaging in preclinical drug development.
    Vanderheyden JL
    Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):374-81. PubMed ID: 19834446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.
    Padia SA; Alessio A; Kwan SW; Lewis DH; Vaidya S; Minoshima S
    J Vasc Interv Radiol; 2013 Aug; 24(8):1147-53. PubMed ID: 23792126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nuclear medicine imaging: new radiotracers and future techniques].
    Semah F
    Neurochirurgie; 2008 May; 54(3):231-5. PubMed ID: 18440564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-invasive radiotracer imaging as a tool for drug development.
    Gibson RE; Burns HD; Hamill TG; Eng WS; Francis BE; Ryan C
    Curr Pharm Des; 2000 Jul; 6(10):973-89. PubMed ID: 10828297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic.
    Wang X; Feng H; Zhao S; Xu J; Wu X; Cui J; Zhang Y; Qin Y; Liu Z; Gao T; Gao Y; Zeng W
    Oncotarget; 2017 Mar; 8(12):20476-20495. PubMed ID: 28108738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of Radiolabeled Molecular Imaging Probes for in Vivo Analysis of Biological Function].
    Ueda M
    Yakugaku Zasshi; 2016; 136(4):659-68. PubMed ID: 27040347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
    Horger M; Bares R
    Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PET and SPECT imaging of the opioid system: receptors, radioligands and avenues for drug discovery and development.
    Lever JR
    Curr Pharm Des; 2007; 13(1):33-49. PubMed ID: 17266587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 18F-Labeled Single-Stranded DNA Aptamer for PET Imaging of Protein Tyrosine Kinase-7 Expression.
    Jacobson O; Weiss ID; Wang L; Wang Z; Yang X; Dewhurst A; Ma Y; Zhu G; Niu G; Kiesewetter DO; Vasdev N; Liang SH; Chen X
    J Nucl Med; 2015 Nov; 56(11):1780-1785. PubMed ID: 26315836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Labelled oligonucleotides as radiopharmaceuticals: pitfalls, problems and perspectives.
    Younes CK; Boisgard R; Tavitian B
    Curr Pharm Des; 2002; 8(16):1451-66. PubMed ID: 12052206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mass effect of injected dose in small rodent imaging by SPECT and PET.
    Kung MP; Kung HF
    Nucl Med Biol; 2005 Oct; 32(7):673-8. PubMed ID: 16243641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiochemistry: A Useful Tool in the Ophthalmic Drug Discovery.
    Pulagam KR; Gómez-Vallejo V; Llop J; Rejc L
    Curr Med Chem; 2020; 27(4):501-522. PubMed ID: 31142249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing antibody pharmacokinetics in mice with in vivo imaging.
    Hoppin J; Orcutt KD; Hesterman JY; Silva MD; Cheng D; Lackas C; Rusckowski M
    J Pharmacol Exp Ther; 2011 May; 337(2):350-8. PubMed ID: 21317355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers in Randomized Clinical Trials: Positron Emission Tomography and Nuclear Medicine Techniques.
    Singhal T; Stern E
    Front Neurol Neurosci; 2016; 39():109-16. PubMed ID: 27463807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.